Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Specific investigations: other studies

Currently viewing:

Administrative data

Link to relevant study record(s)

Description of key information

According to EU Risk Assessment, the mechanism underlying the nephrotoxicity of 1,4-dichlorobenzene in the male F344 rat has been elucidated. It turns out that the 1,4-dichlorobenzene reversibly binds itself to a low molecular weight protein, alpha-2µ-globulin, that is synthesized in the liver of the SD and F344 male rats. The 1,4-diclorobenzene-alpha-2µ-globulin complex can resist the catabolic action of the lysozymes, which then causes a renal lysosomal protein overload and the formation of tubular protein droplets (where the low molecular weight proteins are normally reabsorbed). This lysosomal overload leads to cell death, and then stimulates a secondary cellular proliferation. This alpha-2µ-globulin is specific to male rats. An increase in kidney type alpha-2µ-globulin was detected in urine of male adult SD rats treated with 1,4-dichlorobenzene by gavage and in F344 male rats after single oral administration, with a positive correlation between the male rat nephropathy and 1,4-dichlorobenzene accumulation. The NBR male rats , species not synthesizing alpha-2µ-globulin, did not develop renal lesions or hyaline droplets after oral administration of 1,4-dichlorobenzene (500 mg/kg/day for 4 days). Moreover, a different elimination kinetic was found in male rat kidney from other tissues and could be related to the presence of the protein alpha-2µ-globulin. Compared to the control, an accelerated development of chronic nephrosis appears in treated F344 male rats during the recovery period after cessation of 1,4-dichlorobenzene treatment (9 months inhalation exposure to 75, 300, 600 ppm), in spite of the lack of any persisting alpha-2µ-globulin mediated nephropathy (EU RAR 2004).

Additional information